Page last updated: 2024-10-22

alendronate and Brain Neoplasms

alendronate has been researched along with Brain Neoplasms in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jena, LN1
Bennie, LA1
McErlean, EM1
Pentlavalli, S1
Glass, K1
Burrows, JF1
Kett, VL1
Buckley, NE1
Coulter, JA1
Dunne, NJ1
McCarthy, HO1

Other Studies

1 other study available for alendronate and Brain Neoplasms

ArticleYear
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.
    Journal of nanobiotechnology, 2021, May-04, Volume: 19, Issue:1

    Topics: Alendronate; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Surv

2021